ZOSTER VACCINE, LIVE, (OKA/MERCK)
Herpes Zoster
Louis Stokes VA Medical CentervaccinePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 61/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Herpes Zoster cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Capsaicin NeurogesX | Phase 3 | BBB |
Zoster Vaccine Recombinant, Adjuvanted GlaxoSmithKline | Phase 4 | BBB |
Pregabalin CMH Kharian Medical College | Phase 4 | BB |
Foscarnet Cttq | Phase 4 | BB |
aciclovir Cttq | Phase 4 | BB |
View all 26 →
Same molecule, other indications
ZOSTER VACCINE, LIVE, (OKA/MERCK) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →